1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. Deubiquitinase
  4. USP11 Isoform

USP11

USP11 (ubiquitin-specific peptidase 11) is an X-linked deubiquitinating enzyme of the ubiquitin-specific protease family that primarily regulates protein stability by removing ubiquitin chains from substrate proteins and thereby modulating protein turnover and signaling networks[1]. Mechanistically, USP11 functions in chromatin regulation and the cellular DNA damage response, where it acts as a histone deubiquitinase that contributes to chromatin reorganization during DNA repair processes[2]. Through these activities, USP11 participates in pathways controlling DNA double-strand break repair, cell-cycle progression, and signal transduction, highlighting its importance in maintaining genome integrity[3]. In disease contexts, dysregulated USP11 activity has been linked to multiple cancer models, where stabilization of specific substrates can influence tumor growth, survival, and therapeutic responses[1][3]. Compared with its closest paralogs, USP4 and USP15, USP11 belongs to the same DUSP-UBL domain-containing subfamily but exhibits distinct regulatory mechanisms and substrate specificity despite overall structural similarity, making isoform-selective investigation particularly important for mechanistic studies[3]. This functional divergence has increased interest in USP11 as a research target for understanding deubiquitinase-dependent signaling pathways and disease biology[1][3]. For experimental applications, peptide ligands that recognize a specific ubiquitin-like domain-binding site of USP11 have been developed, providing tools to interrogate USP11-specific molecular interactions[4]. More recently, selective USP11 inhibitors have been reported, enabling pharmacological disruption of USP11-dependent signaling and supporting target-validation studies in cancer research models[5].

USP11 Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-180171
    USP11-IN-1
    Inhibitor
    USP11-IN-1 (Compound 26) is a selective ubiquitin-specific protease 11 (USP11) inhibitor with an IC50 of 10.9 μM. USP11-IN-1 shows IC50 values of 18.1 and >500 μM for USP4 (SI = 1.7 fold) and USP15 (SI > 100 fold). USP11-IN-1 can be used for the research of USP11-related malignant tumors.